产品中心

Cystatin B Recombinant Rabbit mAb

Cat No.: RMA02306
规格:
查看说明书
  • Western blot analysis of Anti-Cystatin B antibody(RMA02306) Gel: 15%SDS-PAGE Lysate: 20 μg Primary antibody: RMA02306(Cystatin B antibody)at dilution 1:1000 Secondary antibody: Goat anti rabbit IgG (SPA10002)at 1:1000 dilution

Product Name: Cystatin B Recombinant Rabbit mAb
Cat No.: RMA02306
Clonality: Monoclonal
Species Reactivity: Human, Rat
Tested Applications: WB,IHC,FC
Recommended Dilution: WB,IHC,FC
Size: 30ul 50ul 100uL
Format: Liquid
Source: Rabbit
Purification Method: Affinity Purification
Isotype: IgG
Conjugate: Un-conjugated
Storage: Store at -20°C. Supplied in 50nM Tris-Glycine(pH 7.4), 0.15M NaCl, 40%Glycerol, 0.01% sodium azide a
Immunogen: A synthetic peptide of human Cystatin-B
Calculated Molecular Weight: 11 kDa
Observed Molecular Weight: 11 kDa
GenBank Accession Number: P04080
Gene ID (NCBI): 1476
Synonyms: PME; ULD; CST6; EPM1; STFB; CPI-B; EPM1A
Background: The cystatin superfamily encompasses proteins that contain multiple cystatin-like sequences. Some of the members are active cysteine protease inhibitors, while others have lost or perhaps never acquired this inhibitory activity. There are three inhibitory families in the superfamily, including the type 1 cystatins (stefins), type 2 cystatins and kininogens. This gene encodes a stefin that functions as an intracellular thiol protease inhibitor. The protein is able to form a dimer stabilized by noncovalent forces, inhibiting papain and cathepsins l, h and b. The protein is thought to play a role in protecting against the proteases leaking from lysosomes. Evidence indicates that mutations in this gene are responsible for the primary defects in patients with progressive myoclonic epilepsy (EPM1). One type of mutation responsible for EPM1 is the expansion in the promoter region of this gene of a CCCCGCCCCGCG repeat from 2-3 copies to 30-78 copies. [provided by RefSeq, Jul 2016]
Category: Primary Ab
武汉天正源生物科技有限公司 版权所有 | 鄂ICP备2023000437号-1